Bath & Body Works To Report Third Quarter Results On November 19, 2026
Investors and analysts interested in participating in the conference call are invited to dial 877-407-9219 (domestic) or 412-652-1274 (international). A telephone replay of the conference call can be accessed by dialing 877-660-6853 (domestic) or 201-612-7415 (international) and entering access code 13762830.
To listen to the audio webcast, please visit the events and presentations page in the Investors section of the company's website at bbwinc.co. The webcast replay will be available approximately three hours following the live call and archived for 90 days.
ABOUT BATH & BODY WORKS:
Bath & Body Works is a global leader in personal care and home fragrance, driven by the belief that everybody deserves to feel good.
The brand's beloved and iconic scents are expertly crafted for exceptional performance and a luxury fragrance experience. Formulated with thoughtfully chosen ingredients, Bath & Body Works' body care products are available in multiple forms including fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and more. The brand's famous 3-wick candles are made with rich, high-quality fragrance oils layered throughout a premium soy wax base, for up to 45 hours of room-filling fragrance.
Consumers can shop Bath & Body Works anytime and anywhere they choose, from welcoming, in-store experiences at more than 1,900 stores in the U.S. and Canada, 550-plus international locations and select Ulta Beauty stores. Online, consumers can visit bathandbodyworks.com, Amazon and Ulta.com.
For further information, please contact:
Bath & Body Works:
Investor Relations
Luke Long
...
Media Relations
Emmy Beach
...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment